Handelsavisen
prelaunch
Companies Healthcare 179290.KQ
17
179290.KQ KOSDAQ Medical Equipment, Supplies & Distribution

MITech Co Ltd

$6 200,00
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
1,94 %
Op margin
41,0 %
ROE
5,9 %
Net margin
42,4 %
Debt / equity
0,01
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

MITech Co Ltd operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to customers in the healthcare sector.

Business. MITech Co Ltd (179290.KQ) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm primarily engages in the sale of medical products, though specific operating segments and geographic breakdowns are not disclosed. Headquartered in South Korea, the company is listed on the KOSDAQ exchange.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
5,9 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 179290.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 179290.KQ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    MITech Co Ltd (179290.KQ) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm primarily engages in the sale of medical products, though specific operating segments and geographic breakdowns are not disclosed. Headquartered in South Korea, the company is listed on the KOSDAQ exchange.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    MITech Co Ltd maintains a strong liquidity position, with a current ratio of 9.65 and cash and equivalents amounting to 19,964,226,330 KRW, indicating a robust ability to meet short-term obligations. The company's debt-to-equity ratio is 0.01, reflecting a conservative capital structure with minimal reliance on debt financing. This low leverage supports financial stability and flexibility in capital allocation.

    In terms of profitability, MITech's return on equity (ROE) is 5.85%, and its return on assets (ROA) is 5.3%, both of which are strong indicators of efficient asset utilization and profitability. These metrics align with the industry's preferred performance indicators, suggesting that the company is performing in line with or above the industry median.

    Geographically and segment-wise, MITech's revenue concentration is not disclosed in the available data, but the company operates in the healthcare services and equipment sector, which is typically less sensitive to geographic volatility. The company's business model is centered around medical equipment and supplies, with a focus on distribution and services.

    Looking at growth, MITech's recent financial performance shows a revenue of 13,268,568,710 KRW and a net income of 5,626,669,410 KRW. While specific growth projections for the next fiscal year are not provided, the company's strong operating cash flow of 5,944,376,970 KRW and free cash flow of 5,831,781,830 KRW suggest a solid foundation for future expansion.

    Risk factors for MITech are currently low, with no immediate filing-based liquidity or dilution flags detected. The company's low debt levels and strong liquidity position reduce the risk of financial distress. Additionally, the absence of dilution potential in the near term supports investor confidence.

    Recent events, including the latest actual EPS of 628.00 KRW and revenue of 67,151,800,000 KRW, indicate consistent performance. These figures align with the company's reported financials and suggest that MITech is meeting or exceeding analyst expectations.

    Key takeaways
    • MITech Co Ltd has a strong liquidity position with a current ratio of 9.65 and minimal debt.
    • The company's ROE of 5.85% and ROA of 5.3% indicate efficient asset utilization and profitability.
    • No immediate liquidity or dilution risks are present, supporting a stable financial outlook.
    • Strong operating and free cash flows suggest a solid foundation for future growth.
    • The company's performance aligns with or exceeds analyst expectations, as reflected in recent EPS and revenue figures.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 3

    With a debt-to-equity ratio of 0.01, MITech maintains a highly conservative capital structure well below the 0.20 cohort median.

    Cash conversion of 1.06 exceeds the 0.84 cohort median, indicating efficient translation of operating income into free cash flow.

    Low dilution, liquidity, and credit risk flags suggest a stable financial profile with minimal immediate threats to shareholder value.

    BEAR CASE · 1

    The four-year revenue CAGR of -2.0% suggests a long-term structural decline in the company's market presence or demand.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-02-25
    Q4 2025 · Quarter highlights

    Revenue KRW 17.18B, +40,4% YoY; Operating income +82,2% YoY.

    RevenueKRW 17.18B+40,4 % YoY
    Operating incomeKRW 4.20B+82,2 % YoY
    Net incomeKRW 5.13B+44,5 % YoY
    Free cash flowKRW 4.39B+20,5 % YoY
    EPS
    Operating cash flowKRW 14.87B−37,1 % YoY
    Financials
    Income statement
    RevenueKRW 17.18B
    Gross profitKRW 9.49B
    Operating incomeKRW 4.20B
    Net incomeKRW 5.13B
    Margins
    Gross margin55.3%
    Operating margin24.4%
    Net margin29.8%
    FCF margin25.6%
    Balance sheet
    Total assetsKRW 141.84B
    Total liabilitiesKRW 15.91B
    Total equityKRW 125.93B
    Cash & equivalentsKRW 39.68B
    Long-term debtKRW 6.86B
    Cash flow
    Operating cash flowKRW 14.87B
    CapEx-KRW 4.96B
    Free cash flowKRW 4.39B
    SBC
    P&L flow · revenue → net income
    Revenue KRW 17.18BOperating costs KRW 12.98BNet income KRW 5.13B
    Highlights
    • Revenue KRW 17.18B, +40,4% YoY
    • Operating income +82,2% YoY
    • Net income +44,5% YoY
    • Free cash flow +20,5% YoY
    • Net margin 29.8%

    Valuation TTM

    Market price
    $6 200,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $96.17B
    Net cash
    $19.28B
    Current ratio
    9.7
    Debt / equity
    0.0
    ROA
    5.3%
    ROE
    5.9%
    Cash conversion
    106.0%
    CapEx / revenue
    -1.6%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin41,0 %Best in class
    Net Margin42,4 %Best in class
    ROE5,9 %Above median
    Capex / Rev-1,6 %Above P75
    D/E0,01Above P75
    Cash Conv1,06Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • MITech Co Ltd Market data — financials · 2026-05-26
    • MITech Co Ltd Market data — analyst estimates · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    179290.KQCanonical
    KOSDAQ · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-02-25 18:52 UTCEARNINGSQuarterly results — Q4 2025 Revenue KRW 17.18B · Net KRW 5.13B
    2026-02-25 18:52 UTCEARNINGSAnnual results — FY 2026 Revenue KRW 67.15B · Net KRW 20.33B
    2025-11-13 06:27 UTCEARNINGSQuarterly results — Q3 2025 Revenue KRW 17.06B · Net KRW 4.94B
    2025-08-13 09:36 UTCEARNINGSQuarterly results — Q2 2025 Revenue KRW 15.67B · Net KRW 4.46B
    2025-05-13 06:07 UTCEARNINGSQuarterly results — Q1 2025 Revenue KRW 17.25B · Net KRW 5.81B
    2025-02-26 07:57 UTCEARNINGSQuarterly results — Q4 2024 Revenue KRW 12.24B · Net KRW 3.55B
    2025-02-26 07:57 UTCEARNINGSAnnual results — FY 2025 Revenue KRW 53.75B · Net KRW 18.29B
    2024-11-12 05:44 UTCEARNINGSQuarterly results — Q3 2024 Revenue KRW 15.44B · Net KRW 4.36B
    2024-08-13 05:48 UTCEARNINGSQuarterly results — Q2 2024 Revenue KRW 12.80B · Net KRW 4.76B
    2024-05-13 07:22 UTCEARNINGSQuarterly results — Q1 2024 Revenue KRW 13.27B · Net KRW 5.63B
    2023-02-27 06:28 UTCEARNINGSAnnual results — FY 2023 Revenue KRW 56.22B · Net KRW 19.15B
    2022-02-21 06:59 UTCEARNINGSAnnual results — FY 2022 Revenue KRW 50.26B · Net KRW 12.25B
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage